Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-049512·BAKER BROS. ADVISORS LP
Schedule 13G ownership disclosure
Candel Therapeutics Inc
Common Stock, par value $0.01 per share · CUSIP: 137404109
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Baker Bros. Advisors LP
Shares: 2,455,108.00 · Class: 4.99%
- Baker Bros. Advisors (GP) LLC
Shares: 2,455,108.00 · Class: 4.99%
- Julian C. Baker
Shares: 2,455,108.00 · Class: 4.99%
- Felix J. Baker
Shares: 2,455,108.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-049512
- Form type
- SCHEDULE 13G/A
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership